相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
Antonio Ceriello et al.
DIABETES CARE (2020)
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Yuchen Chen et al.
DIABETES CARE (2020)
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study
Qiao Shi et al.
DIABETES CARE (2020)
Drugs and the renin-angiotensin system in covid-19
Jeffrey K. Aronson et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends
Antonio Carlo Bossi et al.
DIABETES THERAPY (2020)
Is DPP4 inhibition a comrade or adversary in COVID-19 infection
Rinkoo Dalan
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Practical recommendations for the management of diabetes in patients with COVID-19
Stefan R. Bornstein et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
Emma Barron et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes
Caroline K. Kramer et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Negative control exposure studies in the presence of measurement error: implications for attempted effect estimate calibration
Eleanor Sanderson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma et al.
DIABETOLOGIA (2018)
The importance of defining periods of complete mortality reporting for research using automated data from primary care
Andrew Maguire et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
分享论文
